A recent study also advocates granzyme B (GzmB) based therapeutic approach because GzmB knockout T cells are associated with the production of prominent quantity of proinflammatory cytokines that exacerbated GVHD [74]. This evidence concerns the gene GZMB and graft versus host disease.